MARC Record from marc_columbia

LEADER: 02247cam a22005178a 4500
001 6013257
005 20221121224124.0
008 060615s2007 nju b 001 0 eng
010 $a 2006020032
016 7 $a101279359$2DNLM
020 $a1588296563 (v. 1 : alk. paper)
020 $a1588298906 (v. 2 : alk. paper)
024 3 $a9781588296566
024 3 $a9781588298904
035 $a(OCoLC)ocm70164446
035 $a(NNC)6013257
035 $a6013257
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dBTCTA$dNNC-M
042 $apcc
050 00 $aRC270.3.T84$bT37 2007
060 10 $aW1$bME9616J v.360-361 2007
060 10 $aQV 269$bT185 2007
082 00 $a616.99/4075$222
245 00 $aTarget discovery and validation :$breviews and protocols /$cedited by Mouldy Sioud.
260 $aTotowa, N.J. :$bHumana Press,$c2007.
300 $a2 volumes :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aMethods in molecular biology,$x1064-3745 ;$v360-361
504 $aIncludes bibliographical references and index.
505 0 $av. 1. Emerging strategies for targets and biomarker discovery -- v. 2. Emerging molecular targets and treatment options.
650 0 $aTumor markers.$0http://id.loc.gov/authorities/subjects/sh85138551
650 0 $aBiochemical markers$xTherapeutic use.
650 0 $aDNA microarrays.$0http://id.loc.gov/authorities/subjects/sh99000707
650 0 $aDrug targeting.$0http://id.loc.gov/authorities/subjects/sh88005350
650 0 $aDrugs$xDesign.$0http://id.loc.gov/authorities/subjects/sh88001157
650 0 $aMolecular pharmacology.$0http://id.loc.gov/authorities/subjects/sh86006824
650 12 $aAntineoplastic Agents.$0https://id.nlm.nih.gov/mesh/D000970
650 22 $aDrug Design.$0https://id.nlm.nih.gov/mesh/D015195
650 22 $aBiomarkers, Tumor.$0https://id.nlm.nih.gov/mesh/D014408
700 1 $aSioud, Mouldy.$0http://id.loc.gov/authorities/names/n2003129524
830 0 $aMethods in molecular biology (Clifton, N.J.) ;$vv. 360-361.$0http://id.loc.gov/authorities/names/n92002874
852 01 $boff,hsl$hQH506$i.M56 v.360-v.361
866 41 $80$av.360-v.361
852 01 $bsci$hRC270.3.T84$iT37 2007
866 41 $80$av.1-2